| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.13.1.53 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC352184 |
| https://europepmc.org/articles/PMC352184?pdf=render | ||
| https://journals.asm.org/doi/pdf/10.1128/AAC.13.1.53 | ||
| P932 | PMC publication ID | 352184 |
| P698 | PubMed publication ID | 204250 |
| P5875 | ResearchGate publication ID | 22933252 |
| P2093 | author name string | E. R. Kern | |
| J. C. Overall | |||
| L. A. Glasgow | |||
| Overall JC Jr | |||
| J. T. Richards | |||
| P2860 | cites work | Genital herpesvirus hominis infection in mice. I. Development of an experimental model | Q34116030 |
| Phosphonoacetic Acid in the Treatment of Experimental Herpes Simplex Keratitis | Q34920816 | ||
| Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine | Q34927859 | ||
| Herpesvirus hominis Infection in Newborn Mice: Treatment with Interferon Inducer Polyinosinic-Polycytidylic Acid | Q34932464 | ||
| Prospective Double-Blind Evaluation of Topical Adenine Arabinoside in Male Herpes Progenitalis | Q34958709 | ||
| THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING | Q36266931 | ||
| Suppression of herpes simplex virus infection by phosphonoacetic acid | Q37232354 | ||
| Infection of the newborn with herpesvirus hominis | Q39892994 | ||
| Infection with herpes-simplex viruses 1 and 2. 3. | Q39898637 | ||
| Herpesvirus hominis infection of the female genital tract | Q39920311 | ||
| Resistance to intracerebral challenge in mice immunized against herpes simplex virus | Q39948987 | ||
| Experimental Herpes Simplex Virus Encephalitis: Comparative Effects of Treatment with Cytosine Arabinoside and Adenine Arabinoside | Q39957661 | ||
| Synergistic Antiviral Effects of Adenine Arabinoside and Humoral Antibodies in Experimental Encephalitis Due to Herpesvirus hominis | Q39968669 | ||
| Genital Herpesvirus hominis Infection in Mice. II. Treatment with Phosphonoacetic Acid, Adenine Arabinoside, and Adenine Arabinoside 5'-Monophosphate | Q40066736 | ||
| Immunomodulator-lnduced Resistance Against Herpes Simplex Virus | Q40068692 | ||
| Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study | Q40080447 | ||
| Phosphonoacetic Acid in the Treatment of Experimental Ocular Herpes Simplex Infections | Q40945924 | ||
| Inhibition of herpes simplex virus replication by phosphonoacetic acid | Q41030539 | ||
| Anti-herpes activity of adenine arabinoside monophosphate | Q43446523 | ||
| Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine | Q44460660 | ||
| Comparative effectiveness of six antiviral agents in Herpes simplex type 1 infection of mice | Q44714046 | ||
| Phosphonoacetic acid treatment of shope fibroma and vaccinia virus skin infections in rabbits | Q44854834 | ||
| Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine | Q45818232 | ||
| Studies of the protective effect of gamma globulin against herpes simplex infections in mice. | Q47971334 | ||
| The protective effect of different immunoglobulins against herpetic encephalitis and skin infection in guinea pigs. | Q54101057 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenine | Q15277 |
| pharmacology | Q128406 | ||
| pathogenesis | Q372016 | ||
| P304 | page(s) | 53-60 | |
| P577 | publication date | 1978-01-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid | |
| Alteration of Mortality and Pathogenesis of Three Experimental Herpesvirus hominis Infections of Mice with Adenine Arabinoside 5′-Monophosphate, Adenine Arabinoside, and Phosphonoacetic Acid | |||
| P478 | volume | 13 |
| Q43854215 | Acyclovir treatment of experimental genital herpes simplex virus infections |
| Q28360283 | Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine |
| Q36471790 | Antiviral activity of extracts from marine algae |
| Q42243382 | Arabinosyladenine monophosphate in genital herpes: A double-blind, placebo-controlled study |
| Q34729783 | Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16. |
| Q35668550 | Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis |
| Q28366970 | Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice |
| Q28362122 | Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis |
| Q41971405 | Early and late pathologic changes in the adrenal glands of mice after infection with herpes simplex virus type 1. |
| Q33573365 | Effect of combinations of antiviral drugs on herpes simplex encephalitis. |
| Q45796726 | Establishment and preliminary characterization of a cell line persistently infected with Newcastle disease virus |
| Q45791552 | In vitro andin vivo inhibition of myxoma virus by treatment with phosphonoacetic acid |
| Q39540903 | Ineffectiveness of Topical Adenine Arabinoside 5′-Monophosphate in the Treatment of Recurrent Herpes Simplex Labialis |
| Q39882638 | Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model |
| Q28360471 | Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir |
| Q28333688 | Prolonged and potent therapeutic and prophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]cytosine against herpes simplex virus type 2 infections in mice |
| Q42167768 | Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease |
| Q28366946 | Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus |
| Q28322290 | Treatment of Experimental Herpesvirus Infections with Phosphonoformate and Some Comparisons with Phosphonoacetate |
| Q35673064 | Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice |
| Q35036329 | Use of viral infections in animal models to assess changes in the immune system |
Search more.